Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.

N-acetylcysteine was employed as a therapeutic agent in a 1-year, parallel, double-blind, placebo-controlled, prospective study of 22 patients with progressive systemic sclerosis (PSS). Patients were closely followed-up and were extensively evaluated at baseline, 6 and 12 months. Most parameters rem...

Full description

Saved in:
Bibliographic Details
Main Authors: Furst, D E, Clements, P J, Harris, R, Ross, M, Levy, J, Paulus, H E
Format: Artigo
Language:Inglês
Published: 1979
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1000371/
https://ncbi.nlm.nih.gov/pubmed/386962
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items